These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10477022)

  • 1. Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal model.
    Bohuslavizki KH; Klutmann S; Jenicke L; Brenner W; Feyerabend B; Henze E; Clausen M
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):181-6. PubMed ID: 10477022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary gland protection by S-2-(3-aminopropylamino)-ethylphosphorothioic acid (amifostine) in high-dose radioiodine treatment: results obtained in a rabbit animal model and in a double-blind multi-arm trial.
    Bohuslavizki KH; Klutmann S; Jenicke L; Kröger S; Buchert R; Mester J; Clausen M
    Cancer Biother Radiopharm; 1999 Oct; 14(5):337-47. PubMed ID: 10850318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy.
    Bohuslavizki KH; Brenner W; Klutmann S; Hübner RH; Lassmann S; Feyerabend B; Lüttges J; Tinnemeyer S; Clausen M; Henze E
    J Nucl Med; 1998 Jul; 39(7):1237-42. PubMed ID: 9669401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.
    Bohuslavizki KH; Klutmann S; Bleckmann C; Brenner W; Lassmann S; Mester J; Henze E; Clausen M
    Strahlenther Onkol; 1999 Feb; 175(2):57-61. PubMed ID: 10065139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.
    Bohuslavizki KH; Klutmann S; Brenner W; Mester J; Henze E; Clausen M
    J Clin Oncol; 1998 Nov; 16(11):3542-9. PubMed ID: 9817273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.
    Bohuslavizki KH; Klutmann S; Brenner W; Kröger S; Buchert R; Bleckmann C; Mester J; Henze E; Clausen M
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():6-12. PubMed ID: 10584133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amifostine is a potent radioprotector of salivary glands in radioiodine therapy. Structural and ultrastructural findings.
    Kutta H; Kampen U; Sagowski C; Brenner W; Bohuslavizki KH; Paulsen F
    Strahlenther Onkol; 2005 Apr; 181(4):237-45. PubMed ID: 15827693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer.
    Ma C; Xie J; Chen Q; Wang G; Zuo S
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD007956. PubMed ID: 19821441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
    Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy.
    Raza H; Khan AU; Hameed A; Khan A
    Nucl Med Commun; 2006 Jun; 27(6):495-9. PubMed ID: 16710103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative salivary gland scintigraphy--a recommended examination prior to and after radioiodine therapy].
    Bohuslavizki KH; Brenner W; Lassmann S; Tinnemeyer S; Kalina S; Clausen M; Henze E
    Nuklearmedizin; 1997 Apr; 36(3):103-9. PubMed ID: 9162904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of salivary gland function in thyroid cancer patients treated with radioiodine.
    Malpani BL; Samuel AM; Ray S
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):535-40. PubMed ID: 8655377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine.
    Bohuslavizki KH; Brenner W; Lassmann S; Tinnemeyer S; Tönshoff G; Sippel C; Wolf H; Clausen M; Henze E
    Nucl Med Commun; 1996 Aug; 17(8):681-6. PubMed ID: 8878127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kinetic compartment model for evaluating salivary gland scintigraphies.
    Afzelius P; Fuglsang S
    Clin Physiol Funct Imaging; 2014 Mar; 34(2):143-50. PubMed ID: 23909953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioprotective effect of Ocimum sanctum and amifostine on the salivary gland of rats after therapeutic radioiodine exposure.
    Joseph LJ; Bhartiya US; Raut YS; Hawaldar RW; Nayak Y; Pawar YP; Jambhekar NA; Rajan MG
    Cancer Biother Radiopharm; 2011 Dec; 26(6):737-43. PubMed ID: 22087607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary gland scintigraphy: the use of semiquantitative analysis for uptake and clearance.
    Loutfi I; Nair MK; Ebrahim AK
    J Nucl Med Technol; 2003 Jun; 31(2):81-5. PubMed ID: 12777459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioactive iodine and the salivary glands.
    Mandel SJ; Mandel L
    Thyroid; 2003 Mar; 13(3):265-71. PubMed ID: 12729475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial.
    Upadhyaya A; Zhou P; Meng Z; Wang P; Zhang G; Jia Q; Tan J; Li X; Hu T; Liu N; Wang S; Liu X; Wang H; Zhang C; Zhao F; Yan Z; Wang X; Zhang X; Zhang W
    Nucl Med Commun; 2017 Nov; 38(11):891-903. PubMed ID: 28806348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited cytoprotective effects of amifostine in high-dose radioactive iodine 131-treated well-differentiated thyroid cancer patients: analysis of quantitative salivary scan.
    Kim SJ; Choi HY; Kim IJ; Kim YK; Jun S; Nam HY; Kim JS
    Thyroid; 2008 Mar; 18(3):325-31. PubMed ID: 18341378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal values of [99mTc]pertechnetate uptake and excretion fraction by major salivary glands.
    Anjos DA; Etchebehere EC; Santos AO; Lima MC; Ramos CD; Paula RB; Camargo EE
    Nucl Med Commun; 2006 Apr; 27(4):395-403. PubMed ID: 16531928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.